ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 290 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,423,256 | -25.0% | 3,820 | -23.7% | 0.01% | -30.0% |
| Q4 2022 | $1,896,802 | -99.9% | 5,007 | -36.7% | 0.02% | -33.3% |
| Q3 2022 | $2,794,744,000 | +92717.8% | 7,916 | -0.4% | 0.03% | 0.0% |
| Q2 2022 | $3,011,000 | +9.7% | 7,946 | -8.8% | 0.03% | +42.9% |
| Q1 2022 | $2,746,000 | -83.2% | 8,710 | -81.4% | 0.02% | -65.6% |
| Q4 2021 | $16,370,000 | – | 46,744 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |